Indivior Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Rockville, MD
INDV chart
What traders are saying about $INDV
Latest postsIndivior Pharmaceuticals, Inc. news
- Supernus, Inc. to Participate in the 2026 Jefferies Global Healthcare Conference in London
Yahoo Finance ·
- Supernus (SUPN) Stock Still Looks Undervalued As Its 127% 5 Year Run Continues
Yahoo Finance ·
- Indivior Pharmaceuticals Inc (INDV) stock price, news, quote and history
Yahoo Finance UK ·
- Supernus undervalued after Indivior merger, says Bank of America
proactiveinvestors.com ·
- Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader
BioBuzz ·
- Merger brings 30,099 shares to Indivior (INDV)'s Frank Mottola and converts his equity awards.
Stock Titan ·
- In the merger, Indivior (INDV)’s commercial chief acquires 154,010 stock units.
Stock Titan ·
- A Supernus share exchange gives CFO Timothy C. Dec 14,059 Indivior (INDV) shares.
Stock Titan ·
- Equity awards also converted as director Barlow acquired 41,652 Indivior (INDV) shares in merger.
Stock Titan ·
- Bhatt acquires 28,702 Indivior (INDV) shares in merger; half a converted stock award vests at closing.
Stock Titan ·
- In Indivior (INDV)'s merger, Bethany Sensenig acquires 4,603 stock units and four option awards.
Stock Titan ·
- Indivior Pharmaceuticals, Inc. (INDV) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
Indivior Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.24B | $1.19B | $1.09B | $901.0M |
| Net income | $210.0M | $7.0M | -$126.0M | -$42.0M |
| Diluted EPS | $1.64 | $0.05 | $-0.92 | $-0.30 |
| Total assets (year end) | $1.20B | $1.32B | $1.76B | – |
| Cash and equivalents (year end) | $195.0M | $319.0M | $316.0M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Indivior Pharmaceuticals, Inc.
- Ticker
- INDV (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1625297
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
Frequently asked questions
What exchange is Indivior Pharmaceuticals, Inc. listed on?
Indivior Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol INDV.
What industry is Indivior Pharmaceuticals, Inc. in?
Indivior Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Indivior Pharmaceuticals, Inc. headquartered?
Indivior Pharmaceuticals, Inc.'s business address on file with the SEC is in Rockville, MD.
When does Indivior Pharmaceuticals, Inc.'s fiscal year end?
Indivior Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Indivior Pharmaceuticals, Inc. report?
Indivior Pharmaceuticals, Inc. reported $1.24B in revenue for calendar year 2025, according to its SEC filings.